Blade Therapeutics
South San Francisco, US · Founded 2015 · Delaware corporation · 5 known investors
Biotech
Founders & leadership
WR
Wendye RobbinsExecutive
Board
LE
CW
Cameron WheelerBoard director
PV
EJ
Elaine JonesBoard director
WS
William SlatteryBoard director
JS
James ScopaBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$77M disclosed across 3 rounds · 2016–2019
▶$12MraisedOct 2019 · 21 investors · BiotechnologyRule 506(b)
▶$12MraisedOct 2019 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Prabha IbrahimExecutive Officer
- William V. SlatteryDirector
- James ScopaDirector
- Gary PatouExecutive Officer
- Lloyd B. KlicksteinDirector
- Cameron WheelerDirector
- Peter Van VlasselaerDirector
- Luke EvninDirector
- Wendye Rae RobbinsExecutive Officer, Director
- Rana Al-HallaqDirector
- M. Shirley ChiangExecutive Officer
- Offering amount
- $24M
- Amount sold
- $12M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$38MraisedOct 2019 · 10 investors · BiotechnologyRule 506(b)
▶$38MraisedOct 2019 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rana Al-HallaqDirector
- Wendye Rae RobbinsExecutive Officer, Director
- William V. SlatteryDirector
- James ScopaDirector
- Gary PatouExecutive Officer
- Lloyd B. KlicksteinDirector
- Prabha IbrahimExecutive Officer
- M. Shirley ChiangExecutive Officer
- Cameron WheelerDirector
- Peter Van VlasselaerDirector
- Luke EvninDirector
- Offering amount
- $50M
- Amount sold
- $38M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$27.1MraisedJun 2016 · 10 investors · BiotechnologyRule 506(b)
▶$27.1MraisedJun 2016 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Luke EvninDirector
- Cameron WheelerDirector
- Peter van VlasselaerDirector
- Elaine JonesDirector
- Wendye RobbinsExecutive Officer, Director
- William SlatteryDirector
- James ScopaDirector
- Offering amount
- $45.4M
- Amount sold
- $27.1M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Blade Therapeutics's investors?
- Blade Therapeutics's investors include Bay City Capital, OUP (Osage University Partners), Pfizer Venture Investments, +ND Capital, MPM BioImpact.
- How much funding has Blade Therapeutics raised?
- Blade Therapeutics has disclosed $77M raised across 3 rounds.
- Where is Blade Therapeutics headquartered?
- Blade Therapeutics is headquartered in South San Francisco, US.